N
MBII

Nuveen’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Nuveen’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-166,367
Closed -$188K – 3607
2022
Q1 		$188K Buy
166,367
+5,573
+3% +$4.21K ﹤0.01% 3201
2021
Q4 		$108K Sell
160,794
-11,248
-7% -$9.1K ﹤0.01% 3279
2021
Q3 		$151K Sell
172,042
-49,541
-22% -$59.6K ﹤0.01% 3296
2021
Q2 		$368K Buy
221,583
+34,628
+19% +$57.9K ﹤0.01% 3199
2021
Q1 		$391K Sell
186,955
-7,013
-4% -$14.6K ﹤0.01% 3131
2020
Q4 		$243K Buy
193,968
+10,637
+6% +$12.7K ﹤0.01% 3175
2020
Q3 		$224K Buy
183,331
+1,544
+0.8% +$1.88K ﹤0.01% 3143
2020
Q2 		$213K Buy
181,787
+63,990
+54% +$59.2K ﹤0.01% 3094
2020
Q1 		$96K Sell
117,797
-1,269
-1% -$1.34K ﹤0.01% 3071
2019
Q4 		$120K Sell
119,066
-8,923
-7% -$10.8K ﹤0.01% 3118
2019
Q3 		$181K Hold
127,989
– – ﹤0.01% 3130
2019
Q2 		$192K Buy
+127,989
New +$198K ﹤0.01% 3181

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Nuveen's MBII Position: Q2 2022 in Review

Nuveen sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2022, closing a stake of 166,367 shares — an estimated $188K sold.

Nuveen first reported a position in MBII in Q2 2019 and held it in 12 quarters. The position peaked at $391K in Q1 2021. 62 funds tracked by Wall St. Rank hold MBII as of Q2 2022.

  • Nuveen reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 166,367 Marrone Bio Innovations, Inc. shares in Q2 2022, an estimated $188K.
  • Nuveen first reported a position in Marrone Bio Innovations, Inc. in Q2 2019 and held it in 12 quarters.
  • Nuveen's Marrone Bio Innovations, Inc. position peaked at $391K in Q1 2021.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.